Targeting MDM4 Splicing in Cancers

被引：21

作者：

Bardot, Boris ^{[1
]}

Toledo, Franck ^{[1
]}

机构：

[1] PSL Res Univ, Sorbonne Univ, UPMC Univ Paris 06,Inst Curie,Ctr Rech, CNRS UMR 3244,Genet Suppress Tumorale,Equipe Lab, 26 Rue Ulm, F-75248 Paris 05, France

来源：

GENES | 2017年 / 8卷 / 02期

关键词：

MDM4; MDM2; p53; alternative splicing; isoform; PRE-MESSENGER-RNA; THERAPEUTIC TARGET; P53; INHIBITION; BCL-X; DOMAIN; MICE; EXPRESSION; REVEALS; CELLS; GENE;

D O I：

10.3390/genes8020082

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

MDM4, an essential negative regulator of the P53 tumor suppressor, is frequently overexpressed in cancer cells that harbor a wild-type P53. By a mechanism based on alternative splicing, the MDM4 gene generates two mutually exclusive isoforms: MDM4-FL, which encodes the full-length MDM4 protein, and a shorter splice variant called MDM4-S. Previous results suggested that the MDM4-S isoform could be an important driver of tumor development. In this short review, we discuss a recent set of data indicating that MDM4-S is more likely a passenger isoform during tumorigenesis and that targeting MDM4 splicing to prevent MDM4-FL protein expression appears as a promising strategy to reactivate p53 in cancer cells. The benefits and risks associated with this strategy are also discussed.

引用

页数：6

共 52 条

[1] Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity
Bardot, B.
Bouarich-Bourimi, R.
Leemput, J.
Lejour, V.
Hamon, A.
Plancke, L.
Jochemsen, A. G.
Simeonova, I.
Fang, M.
Toledo, F.
[J]. ONCOGENE, 2015, 34 (22) : 2943 - 2948
[2] Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis
Bartel, F
Schulz, J
Böhnke, A
Blümke, K
Kappler, M
Bache, M
Schmidt, H
Würl, P
Taubert, H
Hauptmann, S
[J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (03) : 469 - 475
[3] Splicing Factor Mutations in Cancer
Bejar, Rafael
[J]. RNA PROCESSING: DISEASE AND GENOME-WIDE PROBING, 2016, 907 : 215 - 228
[4] A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
Bernal, Federico
Wade, Mark
Godes, Marina
Davis, Tina N.
Whitehead, David G.
Kung, Andrew L.
Wahl, Geoffrey M.
Walensky, Loren D.
[J]. CANCER CELL, 2010, 18 (05) : 411 - 422
[5] Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
Bezzi, Marco
Teo, Shun Xie
Muller, Julius
Mok, Wei Chuen
Sahu, Sanjeeb Kumar
Vardy, Leah A.
Bonday, Zahid Q.
Guccione, Ernesto
[J]. GENES & DEVELOPMENT, 2013, 27 (17) : 1903 - 1916
[6] MDMX contains an autoinhibitory sequence element
Bista, Michal
Petrovich, Miriana
Fersht, Alan R.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (44) : 17814 - 17819
[7] Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death
Boesten, L. S. M.
Zadelaar, S. M.
De Clercq, S.
Francoz, S.
van Nieuwkoop, A.
Biessen, E. A. L.
Hofmann, F.
Feil, S.
Feil, R.
Jochemsen, A. G.
Zurcher, C.
Havekes, L. M.
van Vlijmen, B. J. M.
Marine, J. -C
[J]. CELL DEATH AND DIFFERENTIATION, 2006, 13 (12) : 2089 - 2098
[8] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
BOISE, LH
GONZALEZGARCIA, M
POSTEMA, CE
DING, LY
LINDSTEN, T
TURKA, LA
MAO, XH
NUNEZ, G
THOMPSON, CB
[J]. CELL, 1993, 74 (04) : 597 - 608
[9] Detained introns are a novel, widespread class of post-transcriptionally spliced introns
Boutz, Paul L.
Bhutkar, Arjun
Sharp, Phillip A.
[J]. GENES & DEVELOPMENT, 2015, 29 (01) : 63 - 80
[10] Mdmx promotes genomic instability independent of p53 and Mdm2
Carrillo, A. M.
Bouska, A.
Arrate, M. P.
Eischen, C. M.
[J]. ONCOGENE, 2015, 34 (07) : 846 - 856

← 1 2 3 4 5 6 →